首页> 外国专利> Benzimidazole or benzoxazole derivatives for the prevention and treatment of central nervous system diseases, diabetes and its complications

Benzimidazole or benzoxazole derivatives for the prevention and treatment of central nervous system diseases, diabetes and its complications

机译:苯并咪唑或苯并恶唑衍生物预防和治疗中枢神经系统疾病,糖尿病及其并发症

摘要

The present invention provides for the prevention and treatment of central nervous system (CNS) diseases, diabetes, and complications thereof, comprising benzimidazole or benzoxazole derivatives having the structure of Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient A pharmaceutical composition is provided. In the pharmaceutical composition of the present invention, the benzimidazole or benzoxazole derivative used as an active ingredient has an activation mechanism of Nrf2 through the Keap1-Nrf2-ARE pathway and activation of a glutamate transporter such as GLT-1/EAAT, GLAST, etc. By inhibiting oxidative damage in the central nervous system and pancreas through the pathway and inducing the production of antioxidants such as glutathione, the therapeutic effect of central nervous system diseases, diabetes and its complications can be maximized.
机译:本发明提供了中枢神经系统(CNS)疾病,糖尿病及其并发症的预防和治疗,其包含具有式1结构的苯并咪唑或苯并恶唑衍生物作为活性成分的药学上可接受的盐提供药物组合物。在本发明的药物组合物中,用作活性成分的苯并咪唑或苯并恶唑衍生物通过Keap1-NRF2具有NRF2的活化机制 - 是途径和激活谷氨酸转运蛋白,如Glt-1 / Eaat,Glast等。通过途径抑制中枢神经系统和胰腺的氧化损伤,诱导谷胱甘肽等抗氧化剂的生产,中枢神经系统疾病,糖尿病及其并发症的治疗效果可以最大化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号